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Abstract About one third of the population worldwide is
supposed to be salt sensitive which is a major cause for
arterial hypertension later in life. For preventive actions it is
thus desirable to identify salt-sensitive individuals before
the appearance of clinical symptoms. Recent observations
suggest that the vascular endothelium consists of two salt-
sensitive barriers in series, the glycocalyx that buffers sodi-
um and the endothelial cell membrane that contains sodium
channels. Glycocalyx sodium buffer capacity and sodium
channel activity are conversely related to each other. For
proof of concept, a so-called salt provocation test (SPT) was
developed that should unmask vascular salt sensitivity in
humans at virtually any age. Nineteen healthy subjects,
ranging from 25 to 63 years of age, underwent two series
of 1-h blood pressure measurements after acute ingestion of
a salt cocktail with or without addition of a sodium channel
blocker effective in vascular endothelium. Differential anal-
ysis of the changes in diastolic blood pressure (net ΔDP)
identified 12 individuals (63 %) as being salt resistant (net
ΔDP0−0.05±0.62 mmHg) and seven individuals (37 %) as
being salt sensitive (net ΔDP0+6.98±0.75 mmHg). Vascu-
lar salt sensitivity was not related to the age of the study
participants. It is concluded that the SPT could be useful for
identifying vascular salt sensitivity in humans already early
in life.
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Introduction
For many years the kidney was thought to be the major
player due to its ability to regulate body sodium. The focus
has been put on the function of the epithelial sodium chan-
nel (ENaC) localized in the renal collecting duct. The activ-
ity of this channel is under the control of aldosterone, the
key hormone regulating salt and water balance and thus
maintaining body volume and arterial blood pressure. Mal-
function of ENaC, e.g. due to inherited or acquired overac-
tivity, is accompanied by arterial hypertension [4, 10, 11].
It is estimated that at least a third of the population
worldwide is salt sensitive [38], i.e. blood pressure
increases in response to the daily ingestion of large
amounts of sodium, a habit widespread in our societies
[18, 29]. The underlying mechanism is still obscure
although it appears likely that, among other parameters,
renal ENaC activity, and hence sodium accumulation in
the body, plays a role in this scenario [2, 6, 13]. With the
discovery of ENaC in endothelial cells [36] and its
relation to the actin cytoskeleton [12], attention was
directed towards the vascular system. The paradigm shift
that the ENaC regulating hormone aldosterone, besides
the kidney, also acts on extrarenal tissues [21] led to new
insights into the pathophysiology of hypertension and the
use of diuretics in cardiovascular diseases [3, 19, 27]. By
using nanotechniques it was shown that sodium ions as
such can alter the mechanical properties of endothelial
cells and thus control endothelial function [16, 23]. A
closer look at the luminal surface of endothelial cells
revealed that the endothelial glycocalyx (eGC), an anion-
ic biopolymer covering the inner surface of blood vessels
[28, 35, 37], participates in the mechanisms of sodium
homeostasis. The eGC is able to transiently store prefer-
entially sodium ions that are bound, osmotically “silent”,
to the negative charges of proteoglycans [1, 30]. The
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eGC is supposed to serve as a shield against rapid
cellular sodium uptake via the endothelial ENaCs and
thus slows, to some extent, the flux of sodium ions from
the blood into the interstitium [22]. The access of plasma
sodium entering the endothelial cells via the ENaCs is
facilitated when the eGC is compromised, e.g. by high
sodium intake [25]. As a consequence, diuretics as the
ENaC blocker amiloride or related drugs become relevant
for interfering with the function of the endothelium.
Therefore, it was tempting to conclude that challenging
the vascular system with an acute sodium load in pres-
ence of a potent ENaC blocker should transiently change
plasma sodium concentration and/or blood volume, pos-
sibly reflected by a small but measurable change in
blood pressure. This hypothesis was tested in healthy
individuals by the so-called salt provocation test (SPT).
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Data from session A: DP 1,2 … exp – DPcon = ΔDP1,2 … exp (without blocker)
Data from session B: DP 1,2 … exp – DPcon = ΔDP1,2 … exp (with blocker)
ΔDP1,2 … exp (with blocker) – ΔDP 1,2 … exp (without blocker) = net ΔDP
Fig. 1 Experimental procedure
and analysis of the blood
pressure measurements.
Sessions A and B were
randomly performed with a
time difference between
sessions of at least 2 days
Table 1 Baseline characteristics
of study participants











1 29 21.0 m 127/72 60
2 35 22.0 m 114/74 54
3 39 21.6 m 107/71 47
4 26 20.5 f 103/69 78
5 37 23.9 m 139/91 64
6 39 21.0 f 94/62 60
7 29 23.0 f 101/67 69
8 29 26.8 f 108/70 68
9 60 22.0 f 110/71 64
10 27 21.6 f 106/69 60
11 42 31.8 m 120/75 60
12 30 21.1 m 121/82 59
13 33 27.7 m 123/76 73
14 61 23.0 m 138/93 65
15 28 24.5 m 135/86 63
16 25 28.4 f 111/67 71
17 45 23.1 m 112/78 60
18 63 30.9 f 130/95 75
19 54 21.7 f 127/86 66
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Methods
Procedure underlying the SPT
Nineteen healthy study participants (25–63 years of age)
underwent two sessions of blood pressure measurements (up-
per arm, cuff method). At least 2 h prior to the experiments,
study participants stopped any food intake. Measurements
were performed in a sitting position. Figure 1 illustrates the
procedure. In the beginning of the experiment, two control
blood pressure measurements were performed before a salt
cocktail was orally taken. The standard composition of this
cocktail was 5.0 g NaCl and 7.5 g glucose, dissolved in 200ml
water. Then, in 10-min intervals, blood pressure was measured
over 60 min. In session A the salt cocktail (no drugs added)
was applied. In session B, at least 2 days later, drugs (100 mg
triamterene and 50mg hydrochlorothiazide) were added to the
cocktail. It should be noted that the sequence of the sessions
was randomly chosen (A, B or B, A), and the study
participants were not biased by any working hypotheses prior
to the individual sessions.
Calculations
The analyses of the different diastolic blood pressure (DP)
measurements are stepwise illustrated in Fig. 1. In short,
ΔDP (experimental value minus control value) was calcu-
lated for each time point. Then, after completion of both
sessions, the ΔDP obtained in absence of the drugs was
subtracted from the corresponding ΔDP value obtained in
the presence of the drugs. This result leads to a term called
net ΔDP. It is used as a quantitative measure for the indi-
vidual vascular salt sensitivity.
Statistics
Data are shown as mean values±SEM. Significance
of differences was evaluated by the paired/unpaired
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net ΔDP = + 9.33 ± 1.56 mmHg (mean, ± s.e.m.; n=6)
net ΔDP = - 0.02 ± 1.38 mmHg (mean, ± s.e.m.; n=6) net ΔDP = + 3.50 ± 2.75 mmHg (mean, ± s.e.m.; n=6)


























Fig. 2 Changes of diastolic blood pressure, related to the corresponding control value (before the salt load), in response to salt load as indicated.
Four different examples are shown. The numbers in the insets represent the study participant’s number and correspond to the numbers of Fig. 3
Pflugers Arch - Eur J Physiol (2012) 464:287–293 289
Student’s t test if applicable. Overall significance level is
P00.05 or less.
Results
The baseline data of the study participants are summarized
in Table 1. Study participants were healthy, ranging from 25
to 61 years of age, and were under no medical treatment.
Figure 2 shows four examples of the two series of experi-
ments. Diastolic pressure changes, related to the initial control
diastolic pressure and measured over 60 min, are displayed.
Diastolic pressure was preferred for the analysis since systolic
pressure turned out to exhibit a considerable scatter during the
experiment. Figure 2 (upper left part) shows the results of a
29-year-old male “non-responder”. The salt load, combined
with diuretics, did not lead to a significant net ΔDP. Similar
results were obtained in a 60-year-old female participant (low-
er left part). In the upper right part of Fig. 2, the results of a 28-
year-old male study participant are displayed. The netΔDP is
“borderline” in terms of salt sensitivity though missing statis-
tical significance (P>0.05). Clearly salt sensitive is a 63-year-
old female study participant whose net ΔDP is highly signif-
icant (right lower part, P<0.001). The data are summarized in
Fig. 3. Out of 19 study participants, the net ΔDP of 12
individuals was not statistically significant while 7 individuals
showed a significant net ΔDP. Thus, the former group was
termed salt resistant while the latter was termed salt sensitive.
Figure 4 displays the two mean values of netΔDP for the salt-
resistant group (individuals with insignificant netΔDP values)
and the salt-sensitive group (individuals with significant net
ΔDP values) based on the summarized blood pressure meas-
urements (72 measurements in 12 salt-resistant individuals and
42 measurements in 7 salt-sensitive individuals). Figure 5
shows the correlation between the pre-experimental diastolic
pressure of the study participants and netΔDP. The data points
of the salt-sensitive individuals are marked with red circles.
Obviously, there is no significant correlation between the initial
diastolic pressure (before the salt load) and the SPT score (net
ΔDP values). Figure 6 shows the correlation between the age
of the study participants and netΔDP. Again, the data points of
the salt-sensitive individuals were marked with red circles.
Similar as in Fig. 5, there is no significant correlation between
age of the study participants and the SPT score.
Discussion
Salt and blood pressure in humans has been the subject of
passionate debate over decades [5, 14, 17, 18, 34, 39].
Diastolic pressure before experiment (mm Hg)




























Fig. 5 Relationship between the pre-experimental diastolic pressure
and net ΔDP (see Fig. 1 for definition) of each individual. Data points









































Fig. 4 Mean values calculated from the sum of all ΔDP (see Fig. 1 for
definition) obtained in the salt-resistant and the salt-sensitive participants
(number of measurements indicated in/above the respective columns)
Code numbers of study participants






























Fig. 3 Net ΔDP (see Fig. 1 for definition) data of each study partic-
ipant. The green-framed left part of the figure includes the 12 salt-
resistant individuals, the red-framed right part includes the 7
salt-sensitive individuals
290 Pflugers Arch - Eur J Physiol (2012) 464:287–293
Measurements of changes in blood pressure in response to
pure saline infusion can be a possible way to predict salt
sensitivity [31]. However, from a more mechanistic point of
view, such a simple approach may be too error prone. The
reason for this assumption is based on recent experimental
evidence indicating a regulatory role of the endothelium in
sodium metabolism. It was shown previously that an in-
crease of plasma sodium concentration leads to the “stiff
endothelial cell syndrome” [16] resulting in a decrease of
nitric oxide release [23]. An increase in vascular smooth
muscle tone is expected to occur, leading to elevated blood
pressure. Thus, endothelial cells can function as “salt
sensors” [24] and this function may decide on whether an
individual is more or less salt sensitive. This view appears
still too simplistic since the eGC has not yet been taken into
account as a potentially relevant sodium regulatory system.
The eGC, a negatively charged biopolymer, lines the inner
surface of blood vessels and is able to buffer sodium to a
significant amount [1, 25, 30]. Due to the buffering capacity
of the eGC, the access for sodium entering the endothelial
cells via sodium channels is limited. It has been estimated in
in vitro experiments that about 10 % of the overall endothe-
lial “sodium resistance” (i.e. the reciprocal of endothelial
“sodium permeability”) is caused by an intact eGC [26].
When the eGC is poorly developed, then sodium ions have
direct access to the endothelial plasma membrane. Then it
depends on the abundance of ENaCs, regulated by aldoste-
rone similar as in kidney, how avidly sodium can enter the
endothelial cells [15, 25].
When we now reconsider the straightforward approach,
namely using saline infusion to identify salt sensitivity [31],
a problem is likely to occur: A vascular system with a well-
developed eGC will readily buffer the infused sodium and
thus prevent a clear-cut rise in blood pressure. On the other
hand, a vascular system with a poorly developed eGC
allows infused sodium to readily exit the vascular bed,
mediated by the ENaCs. Again, a clear-cut rise of blood
pressure in response to pure saline is unlikely.
A new perspective can be derived from the fact that eGC
function and endothelial ENaC activity are conversely relat-
ed to each other. This is indicated by the observations that a
block of ENaC activity by amiloride is more efficient after































Salt-resistant            Salt-sensitive 
glycocalyx
negatively charged glycosaminoglycans
endothelial cell                               endothelial cell
Fig. 7 Schematic that shows
the proposed mechanism.
“Vascular salt resistance” is
characterized by a well-
developed glycocalyx with an
optimum of negatively charged
proteoglycans that buffer plas-
ma sodium and thus impede the
access of sodium to the respec-
tive channels of the endotheli-
um. In contrast, vascular salt
sensitivity is characterized by a
poorly developed glycocalyx
with a reduced number of neg-
atively charged proteoglycans.
Thus, plasma sodium has facil-
itated access to the sodium
channels of the endothelium
Age of study participants (years)




























Fig. 6 Relationship between participant’s age and netΔDP (see Fig. 1
for definition) of each individual. Data points from salt-sensitive indi-
viduals are marked with red circles. R20correlation coefficient
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the eGC [15] or loss of the heparan sulphate residues caused
by salt excess [25]. Taken together, a simple saline infusion
protocol is not expected to clearly distinguish between salt-
sensitive and salt-resistant individuals. It is obvious that
vascular salt sensitivity depends on at least two parameters,
namely on eGC function and ENaC activity.
This mechanistic view led us to design the SPT. Figure 7
illustrates this concept. The most adequate way, in our view,
is to apply a salt load in the absence and in the presence of a
sodium channel blocker. We assume that a salt-resistant
vasculature (i.e. a well-developed eGC combined with a
low ENaC abundance) should show no significant change
in blood pressure when a salt load is combined with a
sodium channel blocker. In this case, the ingested (or in-
fused) sodium load should be buffered by the eGC and
blood pressure should remain unaffected. However, in an
individual with a salt-sensitive vasculature, the response is
expected to be different. Ingested sodium is insufficiently
buffered by the poorly developed eGC while the high activ-
ity of ENaCs found under these conditions is effectively
inhibited by the sodium channel blocker. Therefore,
ingested sodium circulates as “free (unbound) sodium” for
some limited time in the vasculatory system thereby (tran-
siently) increasing arterial blood pressure. The results of the
present study show that 7 (out of 19) study participants
responded with a significant SPT score (a positive net
ΔDP). These participants (37 %) are supposed to be “salt
sensitive”. The other individuals (63 %) did not respond and
thus are supposed to be “salt resistant”.
We are aware that the number of study participants is
small and thus limits conclusions concerning the percentage
of salt-sensitive individuals in a certain population. Howev-
er, a wide-scale clinical study was not the purpose of this
approach. We rather tested a novel concept (proof of prin-
ciple) of vascular salt sensitivity based on cellular mecha-
nisms obtained recently in vitro [22].
The rationale behind applying glucose together with the
salt load is to increase the velocity of sodium reabsorption in
the intestinal tract. It is well documented that sodium is
transported across the intestinal mucosa together with glu-
cose in a molar stoichiometry of about 2:1 [7]. This stoichi-
ometry is met by using the cocktail applied in the present
study (5 g NaCl/7.5 g glucose).
Triamterene is used as a sodium channel blocker. This
amiloride derivative is in common medical use [9]. A single
dose of 100 mg is obviously sufficient to block the endo-
thelial ENaC for a short period of time. A therapeutic
application of amiloride as an ENaC inhibitor for the treat-
ment of cardiovascular diseases has been proposed previ-
ously [33].
The combination of triamterene (100 mg) with hydro-
chlorothiazide (50 mg) has been chosen only for practical
reasons because this is the mixture usually applied for
medical purposes. Although some direct (rather vasodilata-
tory) effects of hydrochlorothiazides on the endothelium
have been reported [8], the use of this diuretic is most likely
irrelevant for identifying vascular salt sensitivity. However,
this assumption should be further tested.
Addition of glucose to the salt cocktail will stimulate
insulin secretion which is known to have some influence
on nitric oxide release [20]. Thus, blood pressure may
decrease slightly. Indeed we observed in a number of study
participants a small transient decrease in blood pressure
when the salt/glucose cocktail (without drugs) was ingested
(compare Fig. 2, lower right part). This physiological re-
sponse should not affect the impact of the SPT since it
applies for both sessions (cocktail±drugs) and thus cancels
out. However, it explains that in another recent study where
a salty soup without any addition of glucose was offered to
humans, blood pressure slightly increased probably due to
salt-induced volume expansion [32].
Perspectives
Two 1-h sessions, at least 2 days apart from each other,
could be sufficient to characterize the salt sensitivity of the
vasculature in the human. This salt provocation test can be
performed at virtually any age. It should help to predict the
individual’s sensitivity for salt. The SPT is easily performed
in general medical practice and may lead to preventive
measures before cardiovascular malfunction occurs. Since
“vascular salt resistance” of an individual obviously
depends on a well-developed eGC, measures could be taken
to improve eGC function.
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